Sarcoma News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Expert Discusses Promise of CMB305 Immunotherapy Regimen in Sarcoma - Targeted Oncology



Targeted Oncology
 
Expert Discusses Promise of CMB305 Immunotherapy Regimen in Sarcoma 
Targeted Oncology
Somaiah: It can potentially change the landscape for those patients with synovial or myxoid sarcoma who respond well to chemotherapy but ultimately progress. This treatment in those patients with metastatic disease allows them to live longer and can ...

 


Potential Seen for Entrectinib for Specific Patients With Sarcoma Harboring Genetic Rearrangements - Targeted Oncology



Potential Seen for Entrectinib for Specific Patients With Sarcoma Harboring Genetic Rearrangements 
Targeted Oncology
Sankhala noted that it is more challenging to test for genetic rearrangements in patients with bone sarcomas because samples from patients with bone sarcomas are usually not compatible with newer genomic testing technologies. That is why these patients ...

 


Healthy Living: Synovial Sarcoma - 9&10 News



9&10 News
 
Healthy Living: Synovial Sarcoma 
9&10 News
Synovial sarcoma is a rare, aggressive cancer of the soft tissue that can be quite resistant to treatment. Doctors at Fred Hutchinson Cancer Research Center have created a vaccine that's shown some impressive results in a phase one trial, with few ...

 


Global Kaposi Sarcoma Market:Segmental Highlights and Table of Content (2016 ? 2024) - MilTech



Global Kaposi Sarcoma Market:Segmental Highlights and Table of Content (2016 ? 2024) 
MilTech
The global Kaposi Sarcoma Market is segmented on the basis of Type of Treatment,Distribution Channel,Geography. Increased organ transplant procedures are a leading factor driving the Kaposi sarcoma market since the incidence of the cancer is high among ...

and more » 


NanoString-Based Pan-Sarcoma Fusion Gene Assay Shows Promise as First-Line Dx - GenomeWeb



NanoString-Based Pan-Sarcoma Fusion Gene Assay Shows Promise as First-Line Dx 
GenomeWeb
SALT LAKE CITY (GenomeWeb) ? A research team based in British Columbia has developed a sarcoma gene fusion test using NanoString's nCounter platform, which they believe can serve as a first-line clinical diagnostic, replacing multiple individual assays ...

 


Sarcoma Biospy Market Analysis by Manufacturers, Regions, Type and Application, Forecast To 2022 - MilTech



Sarcoma Biospy Market Analysis by Manufacturers, Regions, Type and Application, Forecast To 2022 
MilTech
The Sarcoma Biospy Market Report provides a comprehensive overview including Current scenario and the future growth prospects. The Sarcoma Biospy market report sheds light on the various factors and trends in forthcoming years and key factors behind ...

and more » 


Initial Treatment Approach in Soft Tissue Sarcoma - OncLive



OncLive
 
Initial Treatment Approach in Soft Tissue Sarcoma 
OncLive
So, in a patient with metastatic disease, depending on how many sites of metastasis they have, we do believe that surgery for sarcomas is an incredibly important part of our armamentarium to treat these tumors. We would look to see, is this person ...

and more » 


Lurbinectedin shows activity in pretreated Ewing sarcoma - Healio



Lurbinectedin shows activity in pretreated Ewing sarcoma 
Healio
WAILEA, Hawaii ? Single-agent lurbinectedin induced partial responses among patients with advanced Ewing sarcoma, according to results of multicenter phase 2 basket study presented at the Connective Tissue Oncology Society Annual Meeting. New ...

 


AIM regimen extends PFS, OS in soft tissue sarcoma - Healio



AIM regimen extends PFS, OS in soft tissue sarcoma 
Healio
WAILEA, Hawaii ? The combination of doxorubicin, ifosfamide and mesna significantly improved outcomes among patients with advanced soft tissue sarcomas compared with olaratumab plus doxorubicin, according to retrospective study results presented at ...

 


Aftercare in Sarcoma Should Incorporate Time- and Risk-Adjusted Strategies - Cancer Network



Aftercare in Sarcoma Should Incorporate Time- and Risk-Adjusted Strategies 
Cancer Network
The study included 835 soft-tissue sarcoma patients who were treated with surgery with curative intent between 1994 and 2016. Patients had a median age at surgery of 60 years and were evenly divided between male and female. Liposarcoma accounted for 30 ...

and more »